U
CVR Medical Corp. CVMH.V
TSX
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2022 06/30/2022 03/31/2022 12/31/2021 09/30/2021
Net Income -35.68% -41.29% 90.27% -469.12% -264.86%
Total Depreciation and Amortization -- -- -100.00% 0.00% 0.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 128.77% -70.08% -97.91% 3,988.77% 112.94%
Change in Net Operating Assets -19.53% 54.48% -65.70% 6.62% 57.19%
Cash from Operations -81.22% -78.48% -2.34% 8.88% -298.24%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -100.00% -71.06% 1.11% -5.59%
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -100.00% -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -73.33% 469.62% -93.27% 334.44% -5.59%
Foreign Exchange rate Adjustments 114.45% 289.54% -238.30% -28.35% 156.55%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -299.22% 116.73% -186.05% 2,460.00% 450.00%
Weiss Ratings